BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18363625)

  • 1. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
    Nayak S; Cunliffe M
    Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
    Jensen MP
    Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
    Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report.
    Hans GH; Robert DN; Van Maldeghem KN
    Spinal Cord; 2008 Apr; 46(4):311-3. PubMed ID: 17607309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
    Tremont-Lukats IW; Hutson PR; Backonja MM
    Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
    Hans G; Joukes E; Verhulst J; Vercauteren M
    Curr Med Res Opin; 2009 Nov; 25(11):2737-43. PubMed ID: 19788351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5% lidocaine medicated plaster use in children with neuropathic pain from burn sequelae.
    Orellana Silva M; YaƱez V; Hidalgo G; Valenzuela F; Saavedra R
    Pain Med; 2013 Mar; 14(3):422-9. PubMed ID: 23279572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lidocaine patch: a useful addition to the pain clinic armamentarium.
    Burgess C; Ravenscroft AJ
    Anaesthesia; 2006 Apr; 61(4):412. PubMed ID: 16548983
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response.
    Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS
    Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
    Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
    Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Fogliardi A; Brunori C
    Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
    Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
    Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
    Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
    Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofascial pain response to topical lidocaine patch therapy: case report.
    Dalpiaz AS; Dodds TA
    J Pain Palliat Care Pharmacother; 2002; 16(1):99-104. PubMed ID: 14650453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream].
    Iseki M; Mitsuhata H; Miyazaki T; Toriumi E; Yoshino K
    Masui; 2000 Nov; 49(11):1204-9. PubMed ID: 11215225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of systemic lidocaine in neuropathic pain management.
    Edwards AD
    J Intraven Nurs; 1999; 22(5):273-9. PubMed ID: 10776191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin.
    Wehrfritz A; Namer B; Ihmsen H; Mueller C; Filitz J; Koppert W; Leffler A
    Eur J Pain; 2011 Oct; 15(9):907-12. PubMed ID: 21530339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.